SphygomorCor® offers a better way to detect CVD earlier and target treatment for each individual patient.
Central blood pressure is the best predictor of cardiovascular risk.
All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)
1,400+ studies using the SphygmoCor technology have been published in peer-reviewed clinical publications.
8 out of Top 10 Pharma companies have used SphygmoCor technology in their clinical trials
Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials
Email (required) *
Example: Yes, I would like to receive emails from ATCOR. (You can unsubscribe anytime)
You can unsubscribe at any time